Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
1 Introduction Cancer remains one of the leading causes of death worldwide, with most patients ultimately dying from metastatic disease [1]. Surgery is a cornerstone in the management of solid tumours, with an estimated 60%–80% of cancer patients requiring surgery during the course of their disease [2, 3]. However, both surgical trauma and anaesthetic agents can alter and suppress the immune system, creating a perioperative environment that favours tumour persistence and metastatic spread [4-6].
Summary Anaesthesia may impact long-term cancer survival. In the Cancer and Anaesthesia study, we hypothesised that the hypnotic drug propofol will have an advantage of at least five percentage points in five-year survival over the inhalational anaesthetic sevoflurane for breast cancer surgery.
Authors and Disclosures Mats Enlund, M.D., Ph.D. Center for Clinical Research, Uppsala University, Västerås, Sweden; Department of Anesthesia and Intensive Care, Västmanland Hospital, Västerås, Sweden; European Society of Anaesthesiology and Intensive Care Onco Anesthesiology Research Group, EuroPeriscope, Brussels, Belgium. Anders Berglund, Ph.D. Epistat AB, Uppsala, Sweden.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.